BioStock News

@biostock-news.bsky.social

1 month ago

Active Biotech receives positive feedback to update its tasquinimod study protocol. The changes allow for a broader patient population and combination with either ruxolitinib or momelotinib in the dosing cohort. #ActiveBiotech #biotech

Flemming Leer Jakobsen 🇺🇦🇵🇸🇺🇳🇳🇦

@flemmingleer.bsky.social

8 months ago

How did Sweden create the boom I bioscience specifically in cancer / oncology research and development?

There are a lot of potential cancer treatments in the pipeline from companies like #Bioinvent, #ActiveBiotech and #Isofol plus a lot of other companies. Not to forget #AstraZenaca.